Table 1.
Lipodystrophy | Gene | Clinical Features |
---|---|---|
MAD Type B | ZMPSTE24 | Craniofacial, cutaneous and skeletal abnormalities, premature renal failure and progeroid features, generalized loss of fat22 |
MDP syndrome | POLD1 | Mandibular hypoplasia, deafness and progeroid features, progressive lipodystrophy23 |
Neonatal progeroid syndrome type a | FBN1 | Marfanoid/ progeroid appearance, dilated aortic bulb, bilateral subluxation of the lens, myopia in addition to severe generalized lipodystrophy, and muscle mass, no significant metabolic abnormalities associated with insulin resistance24 |
Nestor-Guillermo Progeria Syndrome | BANF1 | Growth retardation, decreased subcutaneous fat, thin limbs and stiff joints25 |
Keppen-Lubinsky syndrome | KCNJ6 | Severe intellectual disability, microcephaly, developmental delay, prominent large eyes, progeroid features with an open mouth, and generalized lipodystrophy.26 |
SPRTN mutations | SPRTN | Genomic instability, progeroid features, lipodystrophy, and hepatocellular carcinoma27 |
Note: The Werner Syndrome is also included in this category. Data from Wuyts et al19 and Kashyap et al.21
Abbreviations: BANF1, barrier to autointegration factor1; FBN1, fibrillin-1; KCNJ6, potassium inwardly-rectifying channel subfamily J member 6; MAD, mandibuloacral dysplasia; MDP, mandibular hypoplasia, deafness, progeroid features, POLD1, polymerase (DNA) delta 1, catalytic subunit; SPRTN, spartan; ZMPSTE24, zinc metallopeptidaseSTE24.